Major Novartis shareholder calls for board shake-up after drug trial setbacks: Reuters exclusive

Novartis shareholder urges board changes after trial setbacks

A major Novartis shareholder urges board changes to improve oversight after drug trial failures and significant share price declines. Read more at straitstimes.com.

Shake-up Urged at Novartis After $30 Billion Market Loss

Read more about Shake-up Urged at Novartis After $30 Billion Market Loss on Devdiscourse.

Major Novartis shareholder calls for board shake-up after drug trial setbacks: Reuters exclusive

A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker’s board to improve corporate governance after several trial setbacks.

Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks - Regional Media News

By Oliver Hirt and Marleen Kaesebier ZURICH, Sept 10 (Reuters) - A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker's board to improve corporate governance after its shares suffered a record fall this week following back-to-back trial setbacks. David Samra, [...]

Pharmalittle: We're reading about a Novartis investor seeking a shake-up, a Gilead setback, and more

An ongoing shortage of cancer medicines continues to force leading U.S. cancer centers to seek work-around strategies to treat patients.

Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks

By Oliver Hirt and Marleen Kaesebier ZURICH, Sept 10 (Reuters) - A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker's board to improve corporate governance after its shares suffered a record fall this week following back-t...